Franz von Heeren – Sr. Director Business Development and Pharmaceutical Affairs; member of Management Board – Mepha / Teva Switzerland | LinkedIn
![Teva Pharmaceutical Industries. Information about the issuer. (LEI 549300BAFGM4RC74ZJ94, SWIFT TEVPILITXXX). News and credit ratings. Tables with accounting and financial reports. Teva Pharmaceutical Industries. Information about the issuer. (LEI 549300BAFGM4RC74ZJ94, SWIFT TEVPILITXXX). News and credit ratings. Tables with accounting and financial reports.](https://data.cbonds.info/organisations_logos/13739/1506089713teva.png)
Teva Pharmaceutical Industries. Information about the issuer. (LEI 549300BAFGM4RC74ZJ94, SWIFT TEVPILITXXX). News and credit ratings. Tables with accounting and financial reports.
![Teva and Alvotech Announce Strategic Partnership to Collaborate in the U.S. Biosimilar Market | Business Wire Teva and Alvotech Announce Strategic Partnership to Collaborate in the U.S. Biosimilar Market | Business Wire](https://mms.businesswire.com/media/20200805005390/en/739014/23/teva_RGB_JPEG.jpg)